Humacyte (HUMA) Q4 2024 Annual Earnings
HUMA·Reported March 28, 2025·Before market open
Humacyte reported Q4 2024 revenue of $7.2M, beat analyst consensus of $640.2K by $6.6M. Diluted EPS came in at $-0.16, beat the $-0.23 consensus by $0.07.
Revenue
$7.2Mbeat by $6.6M
Consensus: $640.2KDiluted EPS
$-0.16beat by $0.07
Consensus: $-0.23
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Humacyte's Q4 2024 earnings report.
Humacyte (HUMA) reported Q4 2024 earnings on March 28, 2025 before market open.
Humacyte reported revenue of $7.2M and diluted EPS of $-0.16 for Q4 2024.
Revenue beat the consensus estimate of $640.2K by $6.6M. EPS beat the consensus estimate of $-0.23 by $0.07.
You can read the 10-K periodic report (0001818382-25-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.